¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Cardiac septal defect, acquired"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • incongruous field defect
    ºÒÀÏÄ¡½Ã¾ß°á¼Õ
  • luteal phase defect
    Ȳ(»ö)ü±â°á¼Õ
  • migration defect
    ÀÌÁÖ°áÇÔ
  • morphologic defect
    ÇüŰáÇÔ
  • neural tube defect
    ½Å°æ°ü°á¼Õ, ½Å°æ°ü°áÇÔ
  • ostium primum defect
    ù°±¸¸Û°á¼Õ, Á¦1°ø°á¼Õ
  • outflow tract defect
    À¯Ãâ·Î°á¼Õ
  • plication defect
    ÁÖ¸§Çü¼º°áÇÔ
  • perforation defect
    ¶Õ¸²°áÇÔ, õ°ø°áÇÔ
  • perfusion defect
    °ü·ù°á¼Õ
  • scalp defect
    ¸Ó¸®µ¤°³°á¼Õ, µÎÇǰá¼Õ
  • synthesis defect
    ÇÕ¼º°áÇÔ
  • sector defect
    ºÎä²Ã½Ã¾ß°á¼Õ, ¼±Çü½Ã¾ß°á¼Õ
  • sensory defect
    °¨°¢°á¼Õ
  • separation defect
    ºÐ¸®°áÇÔ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • growth defect
    ¼ºÀå°áÇÔ
  • hearing defect
    û°¢Àå¾Ö
  • heritable defect
    À¯Àü°áÇÔ
  • hour-glass filling defect
    ¸ð·¡½Ã°èÃæ¸¸°á¼Õ
  • incongruous field defect
    ºÒÀÏÄ¡½Ã¾ß°á¼Õ
  • migration defect
    ÀÌÁÖ°áÇÔ
  • moral defect
    µµ´ö°áÇÔ
  • morphologic defect
    ÇüŰáÇÔ
  • ostium primum defect
    ù°±¸¸Û°á¼Õ
  • outflow tract defect
    À¯Ãâ·Î°á¼Õ
  • perforation defect
    ¶Õ¸²°áÇÔ
  • perfusion defect
    °ü·ù°á¼Õ
  • plication defect
    ÁÖ¸§Çü¼º°áÇÔ
  • quantum defect
    ¾çÀÚ°á¼Õ
  • relative afferent pupillary defect
    ºñ±³µé½Å°æµ¿°ø°á¼Õ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • acquired immunodeficiency syndrome (AIDS)
    ÈÄõ¼º¸é¿ª°áÇÌÁõ(Èıº)
  • acquired immunodeficiency syndrome(AIDS)
    ÈÄõ¼º ¸é¿ª°áÇÌ ÁõÈıº
  • acquired perforating dermatosis
    ÈÄõ¼º õ°ø¼º ÇǺκ´
  • acquired porphyria cutanea tarda
    ÈÄõ¼º Áö¿¬¼º ÇǺΠÆ÷¸£ÇǸ°Áõ(~ñø)
  • acquired progressive lymphangioma
    ÈÄõ¼º ÁøÇ༺ ¸²ÇÁ°üÁ¾
  • acquired reactive perforating dermatosis
    ÈÄõ¼º ¹ÝÀÀ¼º õ°ø¼º ÇǺκ´
  • acquired resistence
    ȹµæÀúÇ×¼º(¡­î½ù÷àõ).
  • acquired tolerance
    ÈÄõ(¼º) ³»¼º(¡­Ò±àõ), ȹµæ°ü¿ë.
  • acquired tolerance
    ȹµæ°ü¿ë, ÈÄõ¼º°ü¿ë
  • aids=£¾acquired immune deficiency syndrome
    ÈÄõ¼º¸é¿ª°áÇÌÁõÈıº(ý­ô¸àõØóæ¹ÌÀù¹ñøý¦ÏØ)
  • hospital acquired (nosocomial) infection
    ¿ø³»°¨¿°(êÂÒ®Êïæø), º´¿ø°¨¿°.
  • hospital acquired infection
    ¿ø³»°¨¿°, º´¿ø³»°¨¿°
  • ichthyoacanthotoxin, acquired
    ÈÄõ¼º ¾î¸°±Ø¼¼Æ÷µ¶¼Ò.
  • immunodeficiency syndrome, acquired
    ÈÄõ¼º ¸é¿ª°áÇÌ ÁõÈıº
  • primary acquired cholesteatoma
    ÀÏÂ÷(¼º) ÈÄõ(¼º) ÁøÁÖÁ¾
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • ichthyoacanthotoxin, acquired
    ÈÄõ¼º ¾î¸°±Ø¼¼Æ÷µ¶¼Ò.
  • immunity, acquired
    ȹµæ¸é¿ª, ÈÄõ¼º¸é¿ª
  • immunodeficiency syndrome, acquired
    ÈÄõ¼º ¸é¿ª°áÇÌ ÁõÈıº
  • kidney,acquired cystic disease
    ÈÄõ¼º ³¶¼ºÁúȯ(ý­ô¸àõ Ò¥àõòðü´)
  • primary acquired cholesteatoma
    ÀÏÂ÷(¼º) ÈÄõ(¼º) ÁøÁÖÁ¾
  • secondary acquired cholesteatoma
    ÀÌÂ÷ÈÄõ(¼º)ÁøÁÖÁ¾
  • abscess, nasal septal
    ºñÁ߰ݳó¾ç
  • abscess, septal
    ºñÁ߰ݳó¾ç
  • anterior septal branches
    ¾ÕÄÚÁ߰ݰ¡Áö
  • asymmetric septal hypertrophy
    ºñ´ëĪÁ߰ݺñÈÄ.
  • asymmetric septal hypertrophy
    ºñ´ëμº Á߰ݺñ´ë(ÞªÓßöààõ ñḛ́ÝþÓÞ)
  • asymmetric septal hypertrophy
    ºñ´ëĪÁ߰ݺñÈÄ
  • fracture, septal
    (ºñ)Á߰ݰñÀý
  • hematoma, nasal septal
    ºñÁß°ÝÇ÷Á¾
  • hematoma, septal
    (ºñ)Áß°ÝÇ÷Á¾
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • Defect of Skeleton
    »À´ë°áÇÔ
    [¿¾ ¿ë¾î] °ñ°Ý°áÇÔ
  • Septation defect
    »çÀ̸·Çü¼º°áÇÔ
    [¿¾ ¿ë¾î] Áß°ÝÇü¼º°áÇÔ
  • Metabolic defect of pigment (Methemoglobinemia)
    »ö¼Ò´ë»ç°áÇÔ(¸ÞÆ®Çì¸ð±×·ÎºóÇ÷Áõ)
    [¿¾ ¿ë¾î] »ö¼Ò´ë»ç°áÇÔ(¸ÞÆ®Çì¸ð±×·ÎºóÇ÷Áõ)
  • Gametic defect
    »ý½ÄÀÚ°áÇÔ
    [¿¾ ¿ë¾î] »ý½ÄÀÚ°áÇÔ
  • Defect of gametogenesis
    »ý½ÄÀڹ߻ý°áÇÔ
    [¿¾ ¿ë¾î] »ý½ÄÀÚÇü¼º°áÇÔ
  • Congenital defect
    ¼±Ãµ°áÇÔ
    [¿¾ ¿ë¾î] ¼±Ãµ¼º°áÇÔ
  • Congenital metabolic defect
    ¼±Ãµ´ë»ç°áÇÔ
    [¿¾ ¿ë¾î] ¼±Ãµ¼º´ë»ç¼º°áÇÔ
  • Defect of alimentary tract
    ¼ÒÈ­°ü°áÇÔ
    [¿¾ ¿ë¾î] ¼ÒÈ­°ü°áÇÔ
  • Defect of fertilization
    ¼öÁ¤°áÇÔ
    [¿¾ ¿ë¾î] ¼öÁ¤°áÇÔ
  • Metabolic defect of steroid (Adrenogenital syndrome)
    ½ºÅ×·ÎÀ̵å´ë»ç°áÇÔ(ºÎ½Å»ý½Ä±âÁõÈıº)
    [¿¾ ¿ë¾î] ½ºÅ×·ÎÀ̵å´ë»ç°áÇÔ(ºÎ½Å»ý½Ä±âÁõÈıº)
  • Neural defect (Imbecility)
    ½Å°æ°áÇÌ(Ä¡¿ì)
    [¿¾ ¿ë¾î] ½Å°æ°áÇÔ
  • Defect of heart
    ½ÉÀå°áÇÔ
    [¿¾ ¿ë¾î] ½ÉÀå°áÇÔ
  • Heart defect
    ½ÉÀå°áÇÔ
    [¿¾ ¿ë¾î] ½ÉÀå°áÇÔ
  • Metabolic defect of amino acid (Alkaptonuria)
    ¾Æ¹Ì³ë»ê´ë»ç°áÇÔ(¾Ëİſ´¢Áõ)
    [¿¾ ¿ë¾î] ¾Æ¹Ì³ë»ê´ë»ç°áÇÔ(¾Ëİſ´¢Áõ)
  • Amniotic defect
    ¾ç¸·°áÇÔ
    [¿¾ ¿ë¾î] ¾ç¸·°áÇÔ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
ACD absolute cardiac dullness; absolute claudication distance; acid-citrate-dextrose [solution]; actinom...
CAC cardiac-accelerator center; cardiac arrest code; circulating anticoagulant
CAS calcarine sulcus; calcific aortic stenosis; Cancer Attitude Survey; carbohydrate-active steroid; car...
CI cardiac index; cardiac insufficiency; cell immunity; cell inhibition; cephalic index; cerebral infar...
CM California mastitis [test]; calmodulin; capreomycin; carboxymethyl; cardiac murmur; cardiac muscle; ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
IVST interventricular septal thickness
LS lateral septal nucleus
LSN lateral septal nucleus
MS medial septal
MS medial septal nucleus
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • paraplacental chorionic defect
    ÅÂ¹Ý °ç À¶¸ð¸· °áÇÔ
  • perceptual defect
    Áö°¢ °á¼Õ
  • peroxidase defect
    °ú»êÈ­È¿¼Ò °á¼Õ
  • punch out defect
    ±¸¸Û °á¼Õ
  • qualitative platelet defect
    Á¤»ó Ç÷¼ÒÆÇ °áÇÌÁõ, ÁúÀû Ç÷¼ÒÆÇ °áÇÔ
  • quantum defect
    ¾çÀÚ °á¼Õ
  • skeletal defect
    °ñ°Ý °á¼Õ
  • substance defect
    ¹°Áú °áÇÌ
  • superficial defect
    Ç¥À缺 °á¼Õ
  • visual field defect
    ½Ã¾ß °á¼Õ
    ¸Á¸·¿¡¼­ ´ë³ú ÇÇÁú¿¡ À̸£´Â ½Ã°¢°èÀÇ Àå¾Ö·Î ÀÎÇÑ ½Ã¾ßÀÇ ÀÌ»ó.
  • wedge shape defect
    ¼³»ó °á¼Õ
  • window defect
    â¹® ºñħ
  • advanced cardiac life support
    ÀÌÂ÷ ¼Ò»ý¼ú, ÀÌÂ÷ ½ÉÆó¼Ò»ý¼ú
  • black cardiac syndrome
    Èæ½ÉÀå ÁõÈıº
  • borderline cardiac compensation
    ?
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
acquired agammaglobulinaemia Heterogeneous group of immunodeficiency syndromes characterised by hypogammaglobulinaemia of most isotypes, variable B-cell defects, and the presence of recurrent bacterial infections.
(12 Dec 1998)
acquired bronchiectasis <chest medicine> Persistent and progressive dilation of bronchi or bronchioles as a consequence of inflammatory disease (lung infections), obstruction (tumour) or congenital abnormality (for example cystic fibrosis).
Symptoms include fetid breath and paroxysmal coughing, with the expectoration of mucopurulent matter.
It may affect the bronchioles uniformly (cylindric bronchiectasis) or occur in irregular pockets (sacculated bronchiectasis) or the dilated bronchi may have terminal bulbous enlargements (fusiform bronchiectasis).
Although rarely congenital, it is most often an acquired condition in childhood.
(13 Nov 1997)
acquired centric relation See: centric jaw relation.
(05 Mar 2000)
acquired character A character developed in a plant or animal as a result of environmental influences during the individual's life.
(05 Mar 2000)
acquired cuticle A thin film (about 1 um), derived mainly from salivary glycoproteins, which forms over the surface of a cleansed tooth crown when it is exposed to the saliva.
Synonym: acquired cuticle, acquired enamel cuticle, brown pellicle, posteruption cuticle.
(05 Mar 2000)
acquired drives Those drives not directly related to biological needs; a secondary drive can be learned as an offshoot of a primary drive, in which case it is often referred to as a motive.
Synonym: acquired drives.
(05 Mar 2000)
acquired eccentric relation An eccentric relation that is assumed by habit in order to bring the teeth into occlusion.
(05 Mar 2000)
acquired epileptic aphasia <syndrome> Acquired epileptic aphasia. The typical history is that of a child whose development is normal for several years and then, either suddenly or in a fluctuating manner, loses comprehension of speech and the ability to use speech to communicate. The seizures are of no specific type, and are mostly mild and infrequent partial or atypical absences.
(12 Dec 1998)
acquired haemolytic anaemia Nonhereditary acute or chronic anaemia associated with or caused by extracorpuscular factors, e.g., certain infectious agents, chemicals (including autoantibodies or therapeutic agents), burns, toxic materials from higher plant and animal forms (including snake venoms).
(05 Mar 2000)
acquired haemolytic icterus Icterus and anaemia occuring in association with a moderate degree of splenomegaly, increased fragility of red blood cells, and increased amounts of urobilin in the urine.
Synonym: icteroanaemia.
Origin: G. Ikteros
(05 Mar 2000)
acquired hyperlipidaemia <biochemistry> A condition of elevated blood triglycerides or blood cholesterol that is a result of secondary factors (for example poor diet, drug-related causes, diabetes, hypothyroidism, Cushing's syndrome).
(27 Sep 1997)
acquired hyperlipoproteinaemia Nonfamilial hyperlipoproteinaemia that develops as a consequence of some primary disease, such as thyroid deficiency.
(05 Mar 2000)
acquired hypogammaglobulinaemia Heterogeneous group of immunodeficiency syndromes characterised by hypogammaglobulinaemia of most isotypes, variable B-cell defects, and the presence of recurrent bacterial infections.
(12 Dec 1998)
acquired ichthyosis A thickening and scaling of the skin associated with some malignant diseases (e.g., Hodgkin's disease, lymphosarcoma), leprosy, and severe nutritional deficiencies.
(05 Mar 2000)
acquired immunity <immunology> A form of cellular defense which identifies certain foreign substances (antigens) as harmful to the body. For this reason, the body can acquire resistance to a particular foreign agent.
These foreign agents are then attacked by sensitised T lymphocytes (cellular immunity). White blood cells, plasma cells, B lymphocytes and other specialised immune system cells act in concert with T lymphocytes to produce antibodies (humoral immunity) that attach to the antigen directing T-cells to attack.
Antibodies also stimulate the release of special chemical mediators in the blood (for example complement, interferon) that further enhance antigen destruction.
(13 Nov 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á